Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
Last trade$3.82
Day change-$0.115 (-2.93%)
Day range$3.78 – $3.93
Volume319,211
Market cap$191M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$191.3M
Price / earnings
—
Price / book
0.35×
Price / sales
0.14×
EV / sales
0.17×
EV / EBITDA
2.21×
Profitability
Earnings per share
-$4.81
Return on assets
-21.53%
Return on equity
-42.78%
Dividend yield
6.07%
Liquidity and leverage
Debt / equity
0.37×
Current ratio
2.04×
Quick ratio
1.22×
Cash ratio
0.7×
Cash flow
Price / cash flow
12.58×
Price / free cash flow
—
Free cash flow
-$26.26M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for NUS, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$311.01M
$320.11M
$320.61M
$370.32M
$364.21M
$386.14M
$364.49M
$445.55M
Cost of revenue
$108.84M
$101.79M
$106.15M
$108.34M
$107.49M
$120.41M
$117.53M
$166.41M
Gross profit
$202.17M
$218.33M
$214.46M
$261.98M
$256.72M
$265.73M
$246.96M
$279.15M
Selling, general and administrative
$197.08M
$198.77M
$208.6M
$238.74M
$235.08M
$234.95M
$231.75M
$286.35M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$197.08M
$277.64M
$210.44M
$238.74M
$235.08M
$234.95M
$256.86M
$332.23M
Operating income
$5.09M
-$59.32M
$4.03M
$23.24M
$21.64M
$30.78M
-$9.9M
-$53.08M
Interest expense
-$3.5M
-$3.32M
-$4.25M
-$3.99M
-$4.15M
-$2.53M
-$3.28M
-$5.86M
Income before taxes
$1.89M
-$63.18M
$2.6M
$18.19M
$15.99M
$27.41M
$134.6M
-$57.8M
Income taxes
$2.63M
$186.62M
$763K
$3.7M
-$1.09M
$6.29M
$27.09M
-$21.7M
Net income
-$742K
-$249.8M
$1.84M
$14.49M
$17.08M
$21.12M
$107.52M
-$36.11M
Net income attributable to common shareholders
-$742K
-$249.8M
$1.84M
$14.49M
$17.08M
$21.12M
$107.52M
-$36.11M
EBITDA
$17.62M
$32.21M
$18.21M
$36.16M
$33.73M
$43.83M
$29.42M
$9.24M
Basic earnings per share
-$0.02
-$5.14
$0.04
$0.30
$0.35
$0.43
$2.16
-$0.73
Diluted earnings per share
-$0.02
-$5.14
$0.04
$0.28
$0.34
$0.43
$2.14
-$0.73
Recent news
Company coverage with links to the original publishers.
Nu Skin Enterprises reported quarterly earnings of $0.10 per share, missing consensus estimates of $0.21 and falling 71% year-over-year. Revenue also missed expectations at $311.01 million versus $364.21 million a year ago. The stock has declined 48.1% year-to-date and received a Zacks Rank #3 (Hold) rating. Laird Superfood is expected to report results on November 12 with anticipated break-even earnings and significant revenue growth of 239.5% year-over-year.
e.l.f. Beauty reported quarterly earnings of $1.21 per share, significantly beating the consensus estimate of $0.62 per share, representing a 95.16% earnings surprise. The company also exceeded revenue expectations with $520.82 million, up 51.3% year-over-year. With a Zacks Rank #1 (Strong Buy) rating and the stock up 46.6% year-to-date, the cosmetics industry is performing well, ranking in the top 17% of industries. In contrast, Nu Skin Enterprises is expected to report declining earnings and revenues.
The global derma roller market is expected to grow from $303.14 million in 2023 to $668.17 million by 2033, driven by increasing demand for non-invasive cosmetic procedures and growing interest in skincare products.
Nu Skin Enterprises (NUS) shares fell over 3% after the company reported a 12% year-over-year decline in Q2 revenue and a steep drop in non-GAAP net income, despite beating analyst estimates. The company provided guidance for Q3 and full-year 2024, but the earnings forecast fell short of expectations.